ACRX | AcelRx Pharmaceuticals Inc
Category: Consumer goods
Industry: Drug Manufacturers - Major Quick infos Headquarters: Redwood City, California, United States Trade prices Volume: Market Cap: 119.18M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: November 4, 2021
Earnings History Date EPS / Forecast Revenue / Forecast November 11, 2021 August 16, 2021 -0.08 / -0.08443K / 625KMay 17, 2021 -0.08 / -0.0833511K / 1.06MBeat! March 15, 2021 -0.1 / -0.1033738K / 1.74MBeat! November 5, 2020 -0.1 / -0.08251.37M / 2.83Mview more
Historical Data Date Price Open High Low Vol Change ER Oct 8, 2021 0.9920 0.9300 1.0200
0.9100
1.04M -0.8% Oct 7, 2021 1.0000 1.0200 1.0200
1.0000
624.60K -1.96% Oct 6, 2021 1.0200 1.0200 1.0400
1.0000
922.38K 0% Oct 5, 2021 1.0200 1.0200 1.0360
1.0100
570.47K 2% Oct 4, 2021 1.0000 1.0000 1.0283
1.0000
523.16K -0.99% Oct 1, 2021 1.0100 1.0100 1.0400
1.0100
821.20K -0.98% Sep 30, 2021 1.0200 1.0300 1.0400
1.0000
678.68K -0.97% Sep 29, 2021 1.0300 1.0400 1.0800
1.0200
400.10K -0.96% Sep 28, 2021 1.0400 1.0500 1.0800
1.0400
567.27K -2.8% Sep 27, 2021 1.0700 1.0700 1.0800
1.0400
582.66K 0.94% view more
News
AcelRx Pharmaceuticals EPS in-line, misses on revenue seekingalpha.com Aug 17, 2021 4:02 am AcelRx Pharmaceuticals Q2 2021 Earnings Preview seekingalpha.com Aug 16, 2021 5:35 am AcelRx Pharmaceuticals, GBS leads healthcare gainers; Allied Healthcare Products, Allena Pharmaceuticals among seekingalpha.com Jul 14, 2021 11:00 pm October 7, 2020 12:00 PM EDT : AcelRx to Host Virtual KOL Event on Perioperative Use of DSUVIA® ir.acelrx.com Oct 8, 2020 September 16, 2020 4:00 PM EDT : Cantor Fitzgerald Virtual Global Healthcare Conference ir.acelrx.com Sep 17, 2020 4:00 am September 14, 2020 4:30 PM EDT : H.C. Wainwright & Co. 22nd Annual Global Investment Conference ir.acelrx.com Sep 15, 2020 4:30 am
AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results finance.yahoo.com Aug 12, 2020 4:01 pm
AcelRx Pharmaceuticals (ACRX) Moves to Buy: Rationale Behind the Upgrade finance.yahoo.com Aug 11, 2020 12:00 pm AcelRx inks multiple licensing agreements with Aguettant seekingalpha.com Jul 14, 2021 8:53 pm FDA agrees with AcelRx to update promotional materials for Dsuvia seekingalpha.com Jun 17, 2021 8:55 pm Bionano Genomics to join Russell 3000 Index, while AcelRx Pharmaceuticals to see deletion among healthcare stocks seekingalpha.com Jun 15, 2021 4:55 am AcelRx launches Dsuvia study in sickle cell disease presenting to the emergency department seekingalpha.com May 20, 2021 9:59 pm AcelRx shares fall on Q1 topline miss seekingalpha.com May 18, 2021 4:36 am AcelRx Pharmaceuticals EPS in-line, misses on revenue seekingalpha.com May 18, 2021 4:03 am AcelRx Pharma reports study of Dsuvia shows significant reduction in postoperative opioids seekingalpha.com May 13, 2021 8:59 pm AcelRx shares fall after Q4 results, FY forecast seekingalpha.com Mar 16, 2021 4:30 am AcelRx Pharmaceuticals EPS in-line, misses on revenue seekingalpha.com Mar 16, 2021 4:05 am AcelRx to study data on Dsuvia in plastic surgery patients seekingalpha.com Feb 18, 2021 4:54 am AcelRx Pharma sinks as FDA issues warning letter on Dsuvia claims seekingalpha.com Feb 16, 2021 11:42 pm DSS, MARA and BNGO among premarket losers seekingalpha.com Jan 20, 2021 9:31 pm Talk about AcelRx Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
